Smokeless Tobacco
Phase 2Small molecule
Smokeless Tobacco is one of 5 small molecule programs targeting Tobacco-Related Carcinoma. It is currently in Phase 2.
1
Indications
3
Total Trials
1
Active Trials
4
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
5 competitors in Tobacco-Related Carcinoma
#DrugCompanyPhaseTrials
1Nicotine Oral Pouch
OOhio State University Comprehensive Cancer Center
Phase 3
Nicorette
PfizerPhase 1
Nicotinamide
MMetro International Biotech, LLC
Phase 1
Cigarette
OOhio State University Comprehensive Cancer Center
Phase 2
Smokeless Tobacco
OOhio State University Comprehensive Cancer Center
Phase 2
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Smokeless Tobacco. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details